Quick ReadPlain-language overview · read this first
Zhipu (2513.HK) is China's largest independent large-model company, standing on two legs: on-premise deployment plus cloud MaaS. Rating: Avoid — HK$1,040 is paying for an extremely optimistic future ten years out.
Revenue and cash-flow curves point in opposite directions. 2025 revenue was RMB 724 million, up 132%, ranking first with a 6.6% share, but R&D poured in RMB 4.1 billion, the net loss was RMB 4.7 billion, operating cash flow deteriorated from -RMB 68 million to -RMB 2.245 billion over three years, and receivables turnover dragged from 23 days to 112 days. Cloud gross margin recovering from 3.4% to 18.9% counts as improvement, but is still a notch below excellent software companies. P/S of 554x versus SenseTime's mere 13.6x and 4Paradigm's 3-4x: this is not an excellent-company premium but a prepaid price for a distant winner-take-all. A three-tier DCF yields HK$5-10 / 40-70 / 250-350, with the current price about three times the upper edge of the optimistic tier.
The biggest risk is not the company failing but the valuation paradigm switching from "distant platform king" back to "cash-burning AI service provider," which, compounded by cash flow that fails to turn positive, makes a 70%-90% permanent drawdown no black swan. The threshold to re-study is HK$40-80 with operating cash flow clearly turning positive; otherwise, watch without acting.
LeadChina's largest independent large-model company, with 2025 revenue up ~132% to RMB 724 million; yet R&D of RMB 4.1 billion, a net loss of RMB 4.7 billion, and a Reuters price-to-sales ratio of ~554x mean HK$1,040 is paying for an extremely distant, extremely optimistic future with no evidence of free cash flow. Rating: Avoid.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
Investment rating: Avoid.
Core judgment: Zhipu is a company I can broadly understand, but one that currently does not meet the Buffett-style "good business + good price" standard. It sits on a high-growth track, and its technical position and commercialization progress are both respectable: in its prospectus the company calls itself China's largest independent large-model company by revenue and China's second-largest general-purpose large-model developer by revenue. In 2025 revenue rose to RMB 724 million, up about 132% year-on-year. But over the same period, 2025 R&D expenses were about RMB 4.1 billion and the net loss was about RMB 4.718 billion, and in the public materials I can directly verify, sustained, stable, distributable free cash flow still has not appeared. More critically, at the Reuters delayed quote of May 17, 2026, the share price was about HK$1,040 and the market cap about HK$463.68 billion, with Reuters showing a price-to-sales ratio of about 554.55x; this is not paying for current cash flow but for an extremely distant, extremely optimistic future.
Is there a margin of safety at the current price: No.
Suitable investor type: Closer to a high-risk growth / venture-capital-style investor, and not suited to the ordinary long-term value investor who puts "permanent loss of capital" first. Measured against "buying a business that will steadily produce cash over the next 10 years," I think it is currently better suited to being watched rather than allocated to.
Biggest uncertainties: First, whether the business model can produce positive unit economics; second, whether the technical lead can convert into a durable moat; third, whether the current valuation has already priced in most of the success scenarios of the next decade and beyond. Of these three, the third is my clearest negative.
Note on method: Below I explicitly distinguish four types of content: Facts come from the company's prospectus, 2025 results announcement, the company's official results charts, HKEX filings, Reuters, and official regulatory documents; Assumptions are used mainly for valuation; Inferences are logical extensions built on facts; and Opinions are the final investment judgment. You did not fill in "objective / risk appetite," so below I default to the standard of long-term value investing that is highly sensitive to permanent loss.
Understanding the Business
How does this company make money? On the facts, Zhipu was founded in 2019, and its main business is general-purpose large-model services, with a business model split into two parts: on-premise deployment and cloud deployment. The prospectus states that the company provides model services to enterprises and the public sector through its MaaS platform, and also serves individual end users and developers; as of June 30, 2025, the company's models had empowered more than 8,000 institutional clients, and as of the latest practicable date covered about 80 million devices. In 2025, total revenue was RMB 724.3 million, of which on-premise deployment revenue was about RMB 534 million, or 73.7%, and cloud deployment revenue was about RMB 190.4 million, or 26.3%.
Customers, pricing, and revenue predictability. On-premise deployment is more project- or solution-based, usually tied to the client's infrastructure, data, and deployment scenario, with revenue recognition often linked to milestones and acceptance; cloud deployment is more like API/Agent usage-based billing, in theory closer to recurring revenue. The problem is that so far, Zhipu's overall revenue still does not show the "high repeat purchase + high gross margin + high cash-flow predictability" of a traditionally excellent software company. The evidence: the company's cloud deployment gross margin was once only 3.4% in 2024, rebounding to 18.9% in 2025; this shows that although cloud revenue is more "subscription-like," the price war and inference costs are still heavy. Meanwhile, days sales outstanding lengthened from 23 days in 2022 and 21 days in 2023 to 58 days in 2024 and 112 days in the first half of 2025, which also weakens the cash quality of revenue.
Cost structure and dependencies. On the facts, Zhipu's heaviest costs are not manufacturing but R&D, compute, personnel, marketing, and depreciation. The company's R&D expense was RMB 2.195 billion in 2024, rising further to about RMB 4.1 billion in 2025; the prospectus also discloses that one core reason for the sharp rise in 2024 R&D was an increase of about RMB 1.241 billion in compute service fees paid to third-party compute providers. In other words, this business is neither asset-light nor cheap, and it is highly dependent on an external compute ecosystem. The company states clearly in its prospectus that it has no plans to build its own AI data centers, instead procuring compute resources from cloud service providers within China.
Would I hold this business if the stock market were closed for five years? My opinion: at today's price, no. The reason is not that I cannot understand "AI large-model services," but that I have not yet seen this company prove commercially that it can pass through five years of competition, five years of technical iteration, and five years of capex pressure to become a business-ownership asset that steadily generates free cash flow. It looks more like a "candidate platform" still rapidly experimenting, needing continuous financing and continuous competitive wins, than a "good business" that has already established a mature economic model.
Business understandability score: 3/5. The product form is not complex, and the revenue sources are comprehensible; but the long-term economics, customer stickiness, and the mechanism for forming distributable cash flow are still not transparent enough.
Industry & Competition
Industry stage and demand. On the facts, China's AI market grew from RMB 93.7 billion in 2022 to RMB 160.7 billion in 2024, and Frost & Sullivan expects it to reach RMB 993 billion by 2030; within that, China's large-model market is expected to reach RMB 101.1 billion by 2030, a CAGR of about 63.5% from 2024 to 2030. This shows the field itself is a classic high-growth early-stage industry, and long-term demand is not the problem. The problem is that high growth does not equal high profit, and high demand does not equal high return.
Industry structure. Citing Frost & Sullivan data in its prospectus, Zhipu says that by 2024 revenue it is China's largest independent large-model company and China's second-largest general-purpose large-model company, with a market share of about 6.6%. This shows it is not a marginal player but a front-rank one. The prospectus also shows the revenue-share gap among the top five is not large: about 9.4% for the leader, about 6.6% for Zhipu, and about 6.4%, 6.1%, and 4.7% for the next few. This means the profit pool has not yet become highly concentrated, but is still in a stage of multiple strong players coexisting and competing fast on price and performance.
Who are the real strong rivals? My inference: Zhipu's "comparable companies" in the capital markets may be SenseTime, 4Paradigm, and MiniMax; but in industrial reality, the truly hardest opponents are the big-platform players that own cloud, traffic, ecosystem, and customer relationships, along with strong model providers like DeepSeek that disrupt industry pricing with low price and high performance. Reuters reporting on Baidu has already shown that, facing DeepSeek's competitive pressure in 2025, Baidu had to keep doubling down on AI cloud, model open-sourcing, and free-of-charge strategies; this in turn proves how intense the competition is, and shows Zhipu will find it hard to build consumer-goods-like pricing power in the short term.
Is this ultimately a good industry or a bad one? My opinion: this is an industry with very good demand and very brutal competition. It is not "an excellent company in a bad industry," but it is also far from "an easy winner in a good industry." From an owner's perspective, the most valuable thing is not the "halo of the track" but who is finally left standing and who can turn revenue into free cash flow. Today that question has no answer.
Industry attractiveness score: 3/5. Growth is very high, but rapid technical substitution, heavy capital consumption, and many regulatory and geopolitical variables significantly discount the industry's attractiveness.
Moat & Management
Moat assessment. Breaking it down against ten common moat types, my conclusion is: Zhipu has a technical and first-mover advantage, but its moat has not yet been "cemented" into a durable high-return barrier. On brand, the company does have a degree of industry recognition: it launched the GLM framework in 2021 and in 2022 open-sourced China's first ten-billion-parameter-scale model, GLM-130B; as of 2025 the company discloses that its API/Agent platform covers 218 countries and regions, that deep users of its services include 9 of the top 10 internet giants, and that it has 240,000 paying Coding Plan developers and 400,000 paying Claw Plan and product users. All of this shows it is not a model company that "nobody uses."
But from a value-investing angle, what really determines a moat is switching costs, pricing power, cost advantage, distribution advantage, and difficulty of replication. On these dimensions, Zhipu is currently not very strong. On switching costs, once an enterprise has done deep API integration, on-premise deployment, and industry customization, migration costs do rise; but this barrier is far less solid than ERP, databases, or payment networks. On cost advantage, the company's 2025 results chart claims "domestic hardware deployment cuts cost by 50% with no loss of performance," a positive signal, but the financials have not yet proven it has translated into a stable industry-leading margin. On pricing power, the company's 83% API price increase in Q1 2026 is a highlight, yet the overall cloud gross margin is still only 18.9%, so I prefer to see it as a bargaining improvement from a local product upgrade rather than solid pricing power.
Is the moat widening, stable, or narrowing? My view leans cautious: the technical moat is amid rapid iteration, while the commercial moat has not yet formed in step. Open-source models, low-cost inference, and domestic-chip solutions are all advancing in the industry, and this will commoditize "pure model-capability leadership" faster. If Zhipu wants to widen its moat, it must prove two things: first, that the Agent/MaaS platform can form a scale network; second, that platform revenue's gross margin and cash flow can improve markedly with scale. For now, both are still in progress.
Management and shareholder alignment. On the facts, Zhipu is a classic founder-team-led company. The prospectus shows that Liu Debing, Tang Jie, Li Juanzi, Xu Bin, Zhang Peng, and entities controlled by Liu Debing such as Beijing Lianpai, Huihui, and Zhideng form a concert-party controlling-shareholder group; after the IPO (calculated on the unexercised over-allotment), Liu Debing directly holds about 8.97%, Beijing Lianpai about 7.73%, Zhideng about 6.18%, and Tang Jie about 6.10%, with the other founders holding additional direct or platform stakes. Employee holding platforms total about 15.15%. This shows the company is not a structure where "professional managers pocket shareholder capital empty-handed"; both founders and employees are bound into the equity with real money.
Is management trustworthy, and is capital allocation rational? I give a neutral-to-conservative assessment. On the positive side: in the prospectus the company disclosed fairly fully the U.S. Entity List, the EAR, compute dependence, equity incentives, losses, and the no-dividend policy; this shows it does not shy away from core risks. On the negative side: so far, capital allocation is hard to call "excellent." The company pays no dividend and states clearly it will not pay cash dividends for the foreseeable future; net IPO proceeds were about HK$4.1734 billion, of which 70% goes to general large-model R&D, 10% to MaaS platform optimization, 10% to ecosystem/strategic investment, and 10% to working capital, which is unsurprising for a frontier AI company but also means shareholders in the short term are still buying "the right to continued reinvestment" rather than "the right to cash-flow distribution." More notable: after listing, the company announced the acquisition of a target company that mainly holds office property and has been loss-making for the past two years, for a total consideration of up to about RMB 360.52 million, explicitly not using IPO proceeds but paying with internal resources and bank financing; management's stated rationale was to meet office operating needs and optimize asset structure. This deal is not necessarily wrong, but it is clearly not the kind of capital-allocation move that immediately strengthens the AI moat.
Management and capital allocation score: 3/5. Founder shareholding and a long-term orientation are pluses; but large-scale losses, equity-incentive dilution, and the post-IPO non-core asset acquisition keep me from scoring higher for now.
Financial Quality
First, the most important sentence: Zhipu's financial statements contain both real operating pressure and considerable accounting noise. The accounting noise comes mainly from fair-value changes in financial instruments issued to investors and from equity incentives. The prospectus discloses that for 2022–2024 and the first half of 2025, in adjusting net loss the company adds back non-cash items such as "changes in the carrying value of financial instruments issued to investors" and "share-based payments"; this explains why the statutory loss is so large. But this does not mean operations are easy, because real cash flow is equally poor: the company's net operating cash flow for 2022, 2023, and 2024 was -RMB 68.2 million, -RMB 648 million, and -RMB 2.2449 billion respectively. So the loss cannot simply be treated as an accounting illusion.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | RMB 57.4M | RMB 124.5M | RMB 312.4M | RMB 724.3M |
| Gross margin | 54.6% | 64.6% | 56.3% | 41.0% |
| R&D expense | RMB 84.4M | RMB 528.9M | RMB 2.1954B | ~RMB 4.10B |
| Net loss | RMB 143.7M | RMB 788M | RMB 2.958B | RMB 4.7182B |
| Net operating cash flow | -RMB 68.2M | -RMB 648M | -RMB 2.2449B | Unknown |
| Cash & equivalents | RMB 218.9M | RMB 1.2492B | RMB 2.2682B | RMB 2.2591B |
| Trade & other receivables | RMB 27.9M | RMB 416.4M | RMB 666.8M | RMB 698.9M |
| Inventory & contract costs | RMB 10.3M | RMB 28.8M | RMB 32.5M | RMB 125.8M |
| Contract liabilities | RMB 35.2M | RMB 74.1M | RMB 75.1M | RMB 148.6M |
| Property & equipment | RMB 41.4M | RMB 787.5M | RMB 866.4M | RMB 655.8M |
| Bank borrowings | 0 | 0 | RMB 137.2M | RMB 689.5M |
| Lease liabilities | RMB 12.8M | RMB 270.9M | RMB 671.3M | RMB 545.1M |
The table figures are compiled from the prospectus and the 2025 results announcement; the full 2025 cash flow statement was not fully obtained from the directly verifiable sources this time, so operating cash flow and free cash flow are marked "Unknown."
How to read these numbers? First, revenue growth is astonishing. From 2022 to 2025, revenue grew from RMB 57.4 million to RMB 724.3 million, a three-year CAGR of about 133%; this shows commercialization is not absent but is indeed accelerating. Second, gross margin is not stable, declining through 2024 and 2025 after its 2023 peak, and has not yet formed a mature SaaS-style high margin. Third, the expense side far outruns the revenue side. In 2025 alone, R&D was more than five times revenue. This means the company is still in the "the more it grows, the more it must invest" stage, not the "the more it grows, the more cash it produces" stage.
Do profit and cash flow match? No, and they mismatch in a direction unfavorable to shareholders. Operating cash flow was persistently negative from 2022 to 2024 and deteriorated quickly; even looking only at the operating level, 2024 consumed RMB 2.2449 billion in cash. On capex, cash spent on property and equipment was about RMB 506.8 million in 2023 and still RMB 126 million in 2024. From 2022 to 2024, the company was not "poor profit but decent cash," but poor profit and even poorer cash.
Is the balance sheet actually sound? This question must be viewed on two levels: the pre-listing IFRS accounting basis and the economic substance. On the 2025 results-announcement basis, at end-2025 the company had a net-liabilities / net-asset deficit of about RMB 8.111 billion, because "financial instruments issued to investors" were booked as liabilities before listing and reached RMB 10.0732 billion at end-2025, dragging out a very ugly accounting balance sheet. This basis cannot be read like an ordinary industrial company, because the company already listed in January 2026 and these instruments will be reclassified; meanwhile, net IPO proceeds were about HK$4.1734 billion. So on economic substance, Zhipu does not face imminent debt collapse; but from an owner's perspective, this is certainly not a "robust, low-leverage, self-funding" balance sheet.
Are there signs of fraud or aggressive accounting? In the public materials I checked this time, I found no hard evidence directly pointing to financial fraud; the company also discloses that as of the prospectus date it had no off-balance-sheet arrangements. But three things must be tracked closely: first, the lengthening of days sales outstanding; second, the marked rise in contract fulfillment costs / inventory; third, the high share of non-cash items in the loss, which can easily lead investors to misjudge that "the loss is not that big." The conclusion is not "there is fraud" but "the statements are complex; guard against misreading."
Owner Earnings & Valuation
Owner Earnings: face reality first, then talk about the distant future. The core of Buffett-style Owner Earnings is not "adjusted profit" but the cash a business can truly distribute. For Zhipu, the most recent complete cash-flow year I can verify with high confidence is 2024. Taking 2024 as an example, net operating cash flow was about -RMB 2.2449 billion, and cash spent on property and equipment that year was about RMB 126 million. Even if I treat "maintenance capex" very loosely, assuming only half is maintenance and half is expansion, then on a conservative basis 2024 Owner Earnings is still around -RMB 2.3 billion; if all equipment spending is treated as necessary, Owner Earnings is worse. In other words, Zhipu's problem is not that Owner Earnings is "very low" but that it is still significantly negative.
What is the real distributable cash flow in 2025? I can only give a cautious answer: the directly verifiable sources this time are insufficient to precisely give 2025 Owner Earnings. The 2025 results announcement disclosed revenue, gross profit, R&D, administrative expenses, net loss, and the balance sheet, but I did not obtain a complete 2025 cash flow statement from the directly verifiable materials this time, so I will not fabricate a specific number. What can be confirmed is: 2025 R&D rose further to about RMB 4.1 billion while annual revenue was only RMB 724 million; this is the exact opposite of the profile of a company that has already built stable free cash flow.
Valuation method 1: discounted Owner Earnings. The following are my assumptions, not company guidance. To avoid mistaking the story for reality, I use 2025 revenue of RMB 724.3 million as the starting point, assume 10-year revenue CAGR of 35% / 45% / 60% respectively, year-10 Owner Earnings margin of 10% / 15% / 20%, discount rate of 12% / 11% / 10%, terminal growth of 3% / 4% / 4.5%, and only a relatively conservative net-cash adjustment. Under this model, the equity value comes out roughly at: conservative within RMB 2.2 billion, base within RMB 22.5 billion, optimistic within RMB 125 billion. Translated per share, these correspond roughly to the three orders of magnitude HK$5–10, HK$40–70, and HK$250–350. The current price of HK$1,040 is clearly above the upper edge of even my most optimistic scenario. The core here is not "precision to a few dollars" but to show that the current price requires the company to deliver extraordinary growth and profitability over the next decade. The base inputs come from the company's 2025 revenue and current market cap.
Valuation method 2: relative valuation. Reuters shows Zhipu's current price-to-sales ratio at about 554.55x. By comparison, SenseTime's market cap as of mid-May 2026 was about HK$78.523 billion with a P/S of about 13.56x; 4Paradigm's share price as of April–May 2026 was roughly HK$34–38 with a market cap of about HK$20.53 billion, while its 2024 revenue was about RMB 5.261 billion, for a rough P/S of about 3–4x. In other words, Zhipu's P/S is roughly more than 41 times SenseTime's and on the order of a hundred times 4Paradigm's. Even granting that Zhipu is a purer large-model play with a stronger story, this premium is no longer an "excellent-company premium" but more like a "prepaid price for a distant winner-take-all."
Valuation method 3: asset or liquidation value. Per the prospectus, at IPO the unaudited pro forma adjusted tangible net assets per share were about HK$17.85. Per the end-2025 results announcement, the company had about RMB 2.259 billion in cash and equivalents on its books, plus some time deposits and short-term investments, but because pre-listing investor financial instruments are measured as liabilities, the statements show a net-liability position. My conclusion: the asset method can only provide "a very low floor" for this company and can hardly support a high share price. It shows that "the share price is not held up by net assets" and is essentially entirely a bet on future earning power.
Margin-of-safety assessment. Very clear: none. This is a classic case of "possibly a good company, but very likely a bad price." If future growth falls short, margins fail to rise, and valuation multiples revert to the industry norm, then the drawdown may not be mere volatility but permanent loss of capital. If the 554x P/S is simply compressed toward 20x while revenue does not jump significantly, that could in theory cause over 90% of valuation damage; this is of course only an illustrative multiple compression, but it is enough to indicate the direction of risk. The range I give now: no ideal buy price for now; if forced to give one, only at HK$40–80 and when operating cash flow has clearly improved does it begin to have research significance. Above HK$250–350, I already treat it as a clearly overvalued zone; and HK$1,040 is extremely overdrawn on the future. Based on current evidence, I do not recommend any action other than waiting for a "better price."
Risks, Comparison & Final Conclusion
The most important risks and the counterargument. The most core competitive risk is not "Zhipu cannot build models," but that the stronger the models get, the harder they are to monetize. Technical-substitution risk comes from stronger open-source models, cheaper inference, and stronger platform ecosystems; regulatory risk comes from AI content compliance, data, export controls, and geopolitical restrictions; financial risk comes from continued high R&D and compute spending and potential refinancing and dilution; management risk is mainly not integrity but whether it can maintain capital-allocation discipline under high valuation and high capital pressure. In January 2025 the U.S. added Zhipu and its subsidiaries to the Entity List, recorded in both the Federal Register document and Reuters; the company states in its prospectus that this has not yet had a material adverse effect on its business, because it does not build its own AI data centers but procures compute from Chinese cloud service providers, yet this remains an objectively existing and potentially escalating long-term geopolitical risk.
The strongest counterargument is simple: Zhipu may be an excellent technology company, but it is not a proven excellent commercial company; buying today, you are very likely not buying a business but buying expectations themselves. If over the next two or three years revenue keeps growing fast while operating cash flow stays significantly negative, receivables keep lengthening, cloud-platform gross margin fails to approach the level of excellent software companies, and the company still needs financing or dilution to sustain R&D, then today's high valuation is very fragile. For an investor focused on permanent loss of capital, the biggest bad scenario is not "the stock drops 30% short-term" but that the market one day re-recognizes that this is still a large-model company far from self-funding, so the valuation paradigm switches from "distant platform king" back to "cash-burning technical service provider."
Comparison with other opportunities. Compared with listed peers on the same track, Zhipu's valuation is the most aggressive; compared with a broad-based index, Zhipu's single-company execution risk, regulatory risk, and technical-substitution risk are all far higher than the index, and the current price gives you no extra safety cushion; compared with the risk-free return, Reuters reporting that day showed the U.S. 10-year Treasury yield already above 4.5%, meaning the market offers optional returns that require taking none of this single-tech-company risk. My view: buying it is not clearly better than buying an index, let alone clearly better than high-grade bonds / the risk-free rate. If my portfolio could hold only 5 assets, I would not give Zhipu a seat.
Investment Checklist
| Item | Conclusion | Brief judgment |
|---|---|---|
| Can I understand this business | Pass | Can understand product and pricing, but long-term economics still unclear |
| Does it have durable, stable demand | Pass | AI demand very likely exists long-term |
| Does it have a durable moat | Fail | Technical lead exists, but commercial moat unproven |
| Does it have pricing power | Fail | Local improvement, insufficient to prove overall pricing power |
| Can it generate stable free cash flow | Fail | Still large negative cash flow at least through 2024 |
| Is its return on capital excellent | Fail | ROE/ROIC currently not meaningful and negative |
| Is management trustworthy | Uncertain | Founder-led, fairly full disclosure, but capital allocation still to be proven |
| Is capital allocation rational | Uncertain | Most funds into R&D is reasonable, but the subsequent property acquisition needs watching |
| Is the balance sheet sound | Uncertain | Economic substance better than accounting basis, but still far from sound |
| Is valuation below intrinsic value | Fail | Clearly overvalued in all three of my scenarios |
| Is the margin of safety sufficient | Fail | None |
| Does long-term holding let me rest easy | Fail | This price today would not let me rest easy |
| Which key facts would make me sell | Triggers sale if held | Cash-flow deterioration, failed margin improvement, worsening dilution, weakening competitive position |
| Am I buying just because of price rise or emotion | Highly alert | Current valuation is easily emotion-driven |
Final judgment
【Final Rating】 Avoid
【One-sentence investment thesis】 Zhipu may be an important large-model company, but at this stage it is still not a good business proven to produce free cash flow over the long term, while the current price is already priced for an extremely optimistic "future king."
【Core bull case】 The company is in the first tier of China's large-model track and, on the prospectus's basis, is China's largest independent large-model maker; revenue grew rapidly from 2022 to 2025, reaching RMB 724 million in 2025; cloud API/Agent commercialization shows signs of improvement, with API platform revenue rising to RMB 190 million and cloud gross margin back to 18.9%; the founding team holds shares and controls the company through concert-party action, with a relatively clear long-term orientation.
【Core bear case】 Free cash flow has not been established; operating cash flow was persistently negative and deteriorating from 2022 to 2024; 2025 R&D was about RMB 4.1 billion, far above RMB 724 million in revenue; industry competition is extremely intense with fast price and technical iteration; the current P/S is about 554.55x, with almost no margin of safety.
【Key assumptions】 If someone buys today, they are essentially assuming that Zhipu will maintain extremely high revenue growth over the next decade; that the MaaS/Agent platform's gross margin and cash flow will keep improving; that the commercial moat will be strong enough to fend off big-platform players and low-cost open-source models; and that valuation will not revert substantially to the industry norm. If even two or three of these fail to materialize, this investment is prone to failure.
【Fair Buy Price】 Based on my conservative, neutral, and optimistic valuation scenarios, only at HK$40–80 and while seeing operating cash flow clearly turn positive does it approach the "worth re-studying" zone. This range is not a forecast but an expression of the minimum requirement for a "margin of safety."
【Target holding period】 If the fundamentals prove themselves in the future, the holding period can of course exceed 10 years; but at the current price and current commercial maturity, my advice is not "buy and hold long-term" but "do not participate, keep tracking."
【Expected annualized return】 Starting from the current price, my subjective ranges are: the conservative scenario is significantly negative, the neutral scenario is very likely negative, and even the optimistic scenario may not cover the valuation risk. In other words, the return distribution at the current price is not symmetric; downside risk far exceeds upside odds.
【Maximum loss risk】 If industry competition causes the valuation logic to switch from "future platform hegemon" back to "cash-burning AI service provider," compounded by cash flow that keeps failing to turn positive, a drawdown on the order of 70%–90% is not unimaginable. The biggest risk is not short-term volatility but buying at a price that requires extreme success to justify itself.
【Tracking metrics】 If I keep tracking, the metrics I weigh most are: revenue growth; the share of cloud API/Agent revenue; cloud gross margin and blended gross margin; operating cash flow; capex and compute-procurement costs; days sales outstanding; growth in paying developers and paying users; concentration of top-ten customers/suppliers; equity-incentive dilution; and whether further non-core asset acquisitions occur.
【Signals that trigger re-evaluation】 If the following facts appear in the future, I will re-evaluate and possibly raise my view: operating cash flow turns positive for several consecutive periods; cloud gross margin keeps improving and stabilizes at a healthy level; large customers and the developer ecosystem form significant switching costs; the company sustains high-intensity R&D without relying on continuous financing. Conversely, if revenue keeps growing but cash flow keeps deteriorating, receivables lengthen markedly, margin recovery fails, and dilution keeps expanding, I will be even more certain of the "Avoid" judgment.
【Final recommendation】 The calm conclusion is simple: this is not a stock you "should buy just because you're bullish on AI." Viewed through a long-term business-owner lens, it currently looks more like a high-odds but extremely-high-valuation long-dated option than a business already producing steady cash. For long-term value investors who put margin of safety first, my advice is: do not buy, watch patiently, and focus attention on the cash-flow inflection point and on the period after valuation reverts.
Open questions and limitations: The core sources I could directly verify this time include the prospectus, the 2025 results announcement, the company's official 2025 results charts, HKEX filings, and Reuters and U.S. official documents; but the complete 2025 cash flow statement and some finer customer-concentration / segment cash-flow details were not fully obtained from the directly verifiable sources this time, so I deliberately treat the precise value of 2025 Owner Earnings conservatively and explicitly mark it as "unknown / needs additional information."
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free